1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 75, 2024
  5. Article

Annual Review of Medicine

Volume 75, 2024

Mpox: The Reemergence of an Old Disease and Inequities

Abstract

Mpox, previously known as monkeypox, is caused by an related to the variola virus that causes smallpox. Prior to 2022, mpox was considered a zoonotic disease endemic to central and west Africa. Since May 2022, more than 86,000 cases of mpox from 110 countries have been identified across the world, predominantly in men who have sex with men, most often acquired through close physical contact or during sexual activity. The classical clinical presentation of mpox is a prodrome including fever, lethargy, and lymphadenopathy followed by a characteristic vesiculopustular rash. The recent 2022 outbreak included novel presentations of mpox with a predominance of anogenital lesions, mucosal lesions, and other features such as anorectal pain, proctitis, oropharyngeal lesions, tonsillitis, and multiphasic skin lesions. We describe the demographics and clinical spectrum of classical and novel mpox, outlining the potential complications and management.

Keyword(s): AIDS-defining condition, emerging infections, men who have sex with men, monkeypox, mpox, MSM, opportunistic infection, sexually transmitted infections, zoonosis
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-080122-030714
2024-01-29
2024-05-06
Loading full text...

Full text loading...

/deliver/fulltext/med/75/1/annurev-med-080122-030714.html?itemId=/content/journals/10.1146/annurev-med-080122-030714&mimeType=html&fmt=ahah

Literature Cited

  1. 1.
    Magnus PV, Andersen EK, Petersen KB, Birch-Andersen A. 1959. A pox-like disease in cynomolgus monkeys. Acta Pathol. Microbiol. Scand. 46:2156–76
     [Google Scholar]
  2. 2.
    Ladnyj ID, Ziegler P, Kima E. 1972. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull. World Health Organ. 46:5593–97
     [Google Scholar]
  3. 3.
    Bunge EM, Hoet B, Chen L et al. 2022. The changing epidemiology of human monkeypox—a potential threat? A systematic review. PLOS Negl. Trop. Dis. 16:2e0010141
     [Google Scholar]
  4. 4.
    Yong SEF, Ng OT, Ho ZJM et al. 2020. Imported monkeypox, Singapore. Emerg. Infect. Dis. 26:81826–30
     [Google Scholar]
  5. 5.
    Vaughan A, Aarons E, Astbury J et al. 2018. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill. 23:381800509
     [Google Scholar]
  6. 6.
    Erez N, Achdout H, Milrot E et al. 2019. Diagnosis of imported monkeypox, Israel, 2018. Emerg. Infect. Dis. 25:5980–83
     [Google Scholar]
  7. 7.
    Reed KD, Melski JW, Graham MB et al. 2004. The detection of monkeypox in humans in the Western Hemisphere. N. Engl. J. Med. 350:4342–50
     [Google Scholar]
  8. 8.
    Thornhill JP, Barkati S, Walmsley S et al. 2022. Monkeypox virus infection in humans across 16 countries—April–June 2022. N. Engl. J. Med. 387:679–91
     [Google Scholar]
  9. 9.
    WHO 2023. As the mpox “emergency” continues, the United Kingdom shows how achieving and sustaining disease elimination has to be the next priority News Release Feb. 15
  10. 10.
    WHO 2023. 2022–23 Mpox (monkeypox) outbreak: global trends Rep. World Health Organ. Geneva: https://worldhealthorg.shinyapps.io/mpx_global. Accessed June 14, 2023
  11. 11.
    Gastner MT, Seguy V, More P. 2018. Fast flow-based algorithm for creating density-equalizing map projections. PNAS 115:10E2156–64
     [Google Scholar]
  12. 12.
    Esposito JJ, Knight JC. 1985. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology 143:1230–51
     [Google Scholar]
  13. 13.
    Mackett M, Archard L. 1979. Conservation and variation in Orthopoxvirus genome structure. J. Gen. Virol. 45:3683–701
     [Google Scholar]
  14. 14.
    Likos AM, Sammons SA, Olson VA et al. 2005. A tale of two clades: monkeypox viruses. J. Gen. Virol. 86:102661–72
     [Google Scholar]
  15. 15.
    WHO 2018. Monkeypox: experts give virus variants new names News Release, Aug. 12. https://www.who.int/news/item/12-08-2022-monkeypox--experts-give-virus-variants-new-names
  16. 16.
    Arita I, Jezek Z, Khodakevich L, Ruti K. 1985. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am. J. Trop. Med. Hyg. 34:4781–89
     [Google Scholar]
  17. 17.
    Ježek Z, Grab B, Szczeniowski M et al. 1988. Clinico-epidemiological features of monkeypox patients with an animal or human source of infection. Bull. World Health Organ. 66:4459–64
     [Google Scholar]
  18. 18.
    Rimoin AW, Mulembakani PM, Johnston SC et al. 2010. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. PNAS 107:3716262–67
     [Google Scholar]
  19. 19.
    Rimoin AW, Kisalu N, Kebela-Ilunga B et al. 2007. Endemic human monkeypox, Democratic Republic of Congo, 2001–2004. Emerg. Infect. Dis. 13:6934–37
     [Google Scholar]
  20. 20.
    Hoff NA, Morier DS, Kisalu NK et al. 2017. Varicella coinfection in patients with active monkeypox in the Democratic Republic of the Congo. Ecohealth 14:3564–74
     [Google Scholar]
  21. 21.
    Nolen LD, Osadebe L, Katomba J et al. 2016. Extended human-to-human transmission during a monkeypox outbreak in the Democratic Republic of the Congo. Emerg. Infect. Dis. 22:61014–21
     [Google Scholar]
  22. 22.
    Yinka-Ogunleye A, Aruna O, Dalhat M et al. 2019. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report. Lancet Infect. Dis. 19:8872–79
     [Google Scholar]
  23. 23.
    Formenty P, Muntasir MO, Damon I et al. 2010. Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005. Emerg. Infect. Dis. 16:101539–45
     [Google Scholar]
  24. 24.
    Thornhill JP, Palich R, Ghosn J et al. 2022. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series. Lancet 400:103671953–65
     [Google Scholar]
  25. 25.
    Jezek Z, Gromyko AI, Szczeniowski MV. 1983. Human monkeypox. J. Hyg. Epidemiol. Microbiol. Immunol. 27:113–28
     [Google Scholar]
  26. 26.
    Beer EM, Rao VB. 2019. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLOS Negl. Trop. Dis. 13:10e0007791
     [Google Scholar]
  27. 27.
    Zaucha GM, Jahrling PB, Geisbert TW et al. 2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab. Investig. 81:121581–600
     [Google Scholar]
  28. 28.
    Lum FM, Torres-Ruesta A, Tay MZ et al. 2022. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 22:10597–613
     [Google Scholar]
  29. 29.
    Nagata N, Saijo M, Kataoka M et al. 2014. Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey. Int. J. Clin. Exp. Pathol. 7:74359–70
     [Google Scholar]
  30. 30.
    Tree JA, Hall G, Pearson G et al. 2015. Sequence of pathogenic events in cynomolgus macaques infected with aerosolized monkeypox virus. J. Virol. 89:84335–44
     [Google Scholar]
  31. 31.
    Al-Musa A, Chou J, LaBere B. 2022. The resurgence of a neglected orthopoxvirus: immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clin. Immunol. 243:109108
     [Google Scholar]
  32. 32.
    Lu Y, Zhang L. 2020. DNA-sensing antiviral innate immunity in poxvirus infection. Front. Immunol. 11:1637
     [Google Scholar]
  33. 33.
    Song H, Josleyn N, Janosko K et al. 2013. Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLOS ONE 8:10e77804
     [Google Scholar]
  34. 34.
    Earl PL, Americo JL, Moss B. 2020. Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLOS Pathog. 16:4e1008505
     [Google Scholar]
  35. 35.
    Shao L, Huang D, Wei H et al. 2009. Expansion, reexpansion, and recall-like expansion of Vγ2Vδ2 T cells in smallpox vaccination and monkeypox virus infection. J. Virol. 83:2211959–65
     [Google Scholar]
  36. 36.
    Edghill-Smith Y, Golding H, Manischewitz J et al. 2005. Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat. Med. 11:7740–47
     [Google Scholar]
  37. 37.
    Yefet R, Friedel N, Tamir H et al. 2023. Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens. iScience 26:2105957
     [Google Scholar]
  38. 38.
    Agrati C, Cossarizza A, Mazzotta V et al. 2023. Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study. Lancet Infect. Dis. 23:3320–30
     [Google Scholar]
  39. 39.
    Hammarlund E, Dasgupta A, Pinilla C et al. 2008. Monkeypox virus evades antiviral CD4+ and CD8+ T cell responses by suppressing cognate T cell activation. PNAS 105:3814567–72
     [Google Scholar]
  40. 40.
    Alakunle E, Moens U, Nchinda G, Okeke MI. 2020. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses 12:111257
     [Google Scholar]
  41. 41.
    Khodakevich L, Szczeniowski M, Nambu-ma-Disu, et al. 1987. Monkeypox virus in relation to the ecological features surrounding human settlements in Bumba zone, Zaire. Trop. Geogr. Med. 39:156–63
     [Google Scholar]
  42. 42.
    Radonić A, Metzger S, Dabrowski PW et al. 2014. Fatal monkeypox in wild-living sooty mangabey, Côte d'Ivoire, 2012. Emerg. Infect. Dis. 20:61009–11
     [Google Scholar]
  43. 43.
    Nolen LD, Osadebe L, Katomba J et al. 2015. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am. J. Trop. Med. Hyg. 93:2410–15
     [Google Scholar]
  44. 44.
    Tesh RB, Watts DM, Sbrana E et al. 2004. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg. Infect. Dis. 10:91563–67
     [Google Scholar]
  45. 45.
    Damaso CR. 2023. Phasing out monkeypox: mpox is the new name for an old disease. Lancet Reg. Health Am. 17:100424
     [Google Scholar]
  46. 46.
    CDC 2023. Mpox: how it spreads. Centers for Disease Control and Prevention https://www.cdc.gov/poxvirus/mpox/if-sick/transmission.html. Accessed Mar. 4, 2023
    [Google Scholar]
  47. 47.
    Learned LA, Reynolds MG, Wassa DW et al. 2005. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am. J. Trop. Med. Hyg. 73:2428–34
     [Google Scholar]
  48. 48.
    Vaughan A, Aarons E, Astbury J et al. 2020. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerg. Infect. Dis. 26:4782–85
     [Google Scholar]
  49. 49.
    Adler H, Gould S, Hine P et al. 2022. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect. Dis. 27:81153–62
     [Google Scholar]
  50. 50.
    Philpott D, Hughes CM, Alroy KA et al. 2022. Epidemiologic and clinical characteristics of monkeypox cases—United States, May 17–July 22, 2022. Morb. Mortal. Wkly. Rep. 71:321018–22
     [Google Scholar]
  51. 51.
    Mailhe M, Beaumont AL, Thy M et al. 2023. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study. Clin. Microbiol. Infect. 29:2233–39
     [Google Scholar]
  52. 52.
    Moschese D, Pozza G, Giacomelli A et al. 2023. Natural history of human monkeypox in individuals attending a sexual health clinic in Milan, Italy. J. Infect. 86:1e18–20
     [Google Scholar]
  53. 53.
    Angelo KM, Smith T, Camprubí-Ferrer D et al. 2023. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect. Dis. 23:2196–206
     [Google Scholar]
  54. 54.
    Vaughan AM, Cenciarelli O, Colombe S et al. 2022. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Euro Surveill. 27:362200620
     [Google Scholar]
  55. 55.
    Hoffmann C, Jessen H, Wyen C et al. 2022. Clinical characteristics of monkeypox virus infections among men with and without HIV: a large outbreak cohort in Germany. HIV Med. 24:4389–97
     [Google Scholar]
  56. 56.
    Tarín-Vicente EJ, Alemany A, Agud-Dios M et al. 2022. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet 400:10353661–69
     [Google Scholar]
  57. 57.
    Girometti N, Byrne R, Bracchi M et al. 2022. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect. Dis. 22:91321–28
     [Google Scholar]
  58. 58.
    Català A, Clavo-Escribano P, Riera-Monroig J et al. 2022. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases. Br. J. Dermatol. 187:5765–72
     [Google Scholar]
  59. 59.
    Patel A, Bilinska J, Tam JCH et al. 2022. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ 378:e072410
     [Google Scholar]
  60. 60.
    Peiró-Mestres A, Fuertes I, Camprubí-Ferrer D et al. 2022. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill. 27:282200503
     [Google Scholar]
  61. 61.
    Antinori A, Mazzotta V, Vita S et al. 2022. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy. Euro Surveill. 27:222200421
     [Google Scholar]
  62. 62.
    Lapa D, Carletti F, Mazzotta V et al. 2022. Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding. Lancet Infect. Dis. 22:91267–69
     [Google Scholar]
  63. 63.
    Palich R, Burrel S, Monsel G et al. 2023. Viral loads in clinical samples of men with monkeypox virus infection: a French case series. Lancet Infect. Dis. 23:174–80
     [Google Scholar]
  64. 64.
    Moschese D, Pozza G, Mileto D et al. 2022. Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022. Euro Surveill. 27:362200675
     [Google Scholar]
  65. 65.
    Allan-Blitz L-T, Gandhi M, Adamson P et al. 2022. A position statement on mpox as a sexually transmitted disease. Clin. Infect. Dis. 76:81508–12
     [Google Scholar]
  66. 66.
    Mbala PK, Huggins JW, Riu-Rovira T et al. 2017. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J. Infect. Dis. 216:7824–28
     [Google Scholar]
  67. 67.
    Osadebe L, Hughes CM, Shongo Lushima R et al. 2017. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo. PLOS Negl. Trop. Dis. 11:9e0005857
     [Google Scholar]
  68. 68.
    WHO 2022. Laboratory testing for the monkeypox virus: interim guidance Publication WHO/MPX/Laboratory/2022.1 World Health Organ. Geneva. Corrigenda: June 22, 2022 and June 27, 2022. https://www.who.int/publications/i/item/WHO-MPX-laboratory-2022.1
  69. 69.
    WHO 2022. Surveillance, case investigation and contact tracing for mpox (monkeypox): interim guidance, 22 December 2022 Tech. Doc. WHO/MPX/Surveillance/2022.4 World Health Organ. Geneva: https://www.who.int/publications/i/item/WHO-MPX-Surveillance-2022.4. Accessed Mar. 4, 2023
  70. 70.
    Otter AD, Jones S, Hicks B et al. 2022. Analogous humoral antigen recognition between monkeypox-infected and smallpox-vaccinated individuals. medRxiv 2022.12.22.22283648
  71. 71.
    Charniga K, Masters NB, Slayton RB et al. 2022. Estimating the incubation period of monkeypox virus during the 2022 multi-national outbreak. medRxiv 2022.06.22.22276713
  72. 72.
    Gomez-Garberi M, Sarrio-Sanz P, Martinez-Cayuelas L et al. 2022. Genitourinary lesions due to monkeypox. Eur. Urol. 82:6625–30
     [Google Scholar]
  73. 73.
    Ogoina D, Iroezindu M, James HI et al. 2020. Clinical course and outcome of human monkeypox in Nigeria. Clin. Infect. Dis. 71:8e210–14
     [Google Scholar]
  74. 74.
    Huhn GD, Bauer AM, Yorita K et al. 2005. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin. Infect. Dis. 41:121742–51
     [Google Scholar]
  75. 75.
    Breman JG. 2000. Monkeypox: an emerging infection for humans?. Emerg. Infect. 4:45–67
     [Google Scholar]
  76. 76.
    Breman JG, Kalisa R, Steniowski MV et al. 1980. Human monkeypox, 1970–79. Bull. World Health Organ. 58:2165–82
     [Google Scholar]
  77. 77.
    Gedela K, Da Silva Fontoura D, Salam A et al. 2023. Infectious proctitis due to human mpox. Clin. Infect. Dis. 76:3e1424–27
     [Google Scholar]
  78. 78.
    Curran KG, Eberly K, Russell OO et al. 2022. HIV and sexually transmitted infections among persons with monkeypox—eight U.S. jurisdictions, May 17–July 22, 2022. Morb. Mortal. Wkly. Rep. 71:361141–47
     [Google Scholar]
  79. 79.
    Moschese D, Giacomelli A, Beltrami M et al. 2022. Hospitalisation for monkeypox in Milan, Italy. Travel. Med. Infect. Dis. 49:102417
     [Google Scholar]
  80. 80.
    Miller MJ, Cash-Goldwasser S, Marx GE et al. 2022. Severe monkeypox in hospitalized patients—United States, August 10–October 10, 2022. Morb. Mortal. Wkly. Rep. 71:441412–17
     [Google Scholar]
  81. 81.
    Mbala PK, Huggins JW, Riu-Rovira T et al. 2017. Maternal and fetal outcomes among pregnant women with human monkeypox infection in the Democratic Republic of Congo. J. Infect. Dis. 216:7824–28
     [Google Scholar]
  82. 82.
    Oakley LP, Hufstetler K, O'Shea J et al. 2023. Mpox cases among cisgender women and pregnant persons—United States, May 11–November 7, 2022. Morb. Mortal. Wkly. Rep. 72:19–14
     [Google Scholar]
  83. 83.
    Hennessee I, Shelus V, McArdle CE et al. 2022. Epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox—United States, May 17–September 24, 2022. Morb. Mortal. Wkly. Rep. 71:441407–11
     [Google Scholar]
  84. 84.
    Mitjà O, Alemany A, Marks M et al. 2023. Mpox in people with advanced HIV infection: a global case series. Lancet 401:10380939–49
     [Google Scholar]
  85. 85.
    Mondi A, Gagliardini R, Mazzotta V et al. 2023. Clinical experience with use of oral tecovirimat or intravenous cidofovir for the treatment of monkeypox in an Italian reference hospital. J. Infect. 86:166–117
     [Google Scholar]
  86. 86.
    Matias WR, Koshy JM, Nagami EH et al. 2022. Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, United States. Open Forum Infect. Dis. 9:8ofac377
     [Google Scholar]
  87. 87.
    Grosenbach DW, Honeychurch K, Rose EA et al. 2018. Oral tecovirimat for the treatment of smallpox. N. Engl. J. Med. 379:144–53
     [Google Scholar]
  88. 88.
    Desai AN, Thompson GR 3rd, Neumeister SM et al. 2022. Compassionate use of tecovirimat for the treatment of monkeypox infection. JAMA 328:131348–50
     [Google Scholar]
  89. 89.
    Stafford A, Rimmer S, Gilchrist M et al. 2023. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Lancet Infect. Dis. 23:6e218–26
     [Google Scholar]
  90. 90.
    Raccagni AR, Candela C, Bruzzesi E et al. 2023. Real-life use of cidofovir for the treatment of severe monkeypox cases. J. Med. Virol. 95:1e28218
     [Google Scholar]
  91. 91.
    Shchelkunova GA, Shchelkunov SN. 2022. Smallpox, monkeypox and other human orthopoxvirus infections. Viruses 15:1103
     [Google Scholar]
  92. 92.
    Shchelkunov SN, Totmenin AV, Safronov PF et al. 2002. Analysis of the monkeypox virus genome. Virology 297:2172–94
     [Google Scholar]
  93. 93.
    Manes NP, Estep RD, Mottaz HM et al. 2008. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. J. Proteome Res. 7:3960–68
     [Google Scholar]
  94. 94.
    Fine PE, Jezek Z, Grab B, Dixon H. 1988. The transmission potential of monkeypox virus in human populations. Int. J. Epidemiol. 17:3643–50
     [Google Scholar]
  95. 95.
    Poland GA, Kennedy RB, Tosh PK. 2022. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect. Dis. 22:12e349–58
     [Google Scholar]
  96. 96.
    Wolff Sagy Y, Zucker R, Hammerman A et al. 2023. Real-world effectiveness of a single dose of mpox vaccine in males. Nat. Med. 29:748–52
     [Google Scholar]
  97. 97.
    Thy M, Peiffer-Smadja N, Mailhe M et al. 2022. Breakthrough infections after postexposure vaccination against mpox. N. Engl. J. Med. 387:262477–79
     [Google Scholar]
  98. 98.
    Jones TC, Schneider J, Mühlemann B et al. 2022. Genetic variability, including gene duplication and deletion, in early sequences from the 2022 European monkeypox outbreak. bioRxiv 2022.07.23.501239 https://doi.org/10.1101/2022.07.23.501239
  99. 99.
    Isidro J, Borges V, Pinto M et al. 2022. Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nat. Med. 28:81569–72
     [Google Scholar]
  100. 100.
    Gigante CM, Korber B, Seabolt MH et al. 2022. Multiple lineages of monkeypox virus detected in the United States, 2021–2022. Science 378:6619560–65
     [Google Scholar]
  101. 101.
    Paparini S, Whitacre R, Smuk M et al. 2023. Public understanding and awareness of and response to monkeypox virus outbreak: a cross-sectional survey of the most affected communities in the United Kingdom during the 2022 public health emergency. HIV Med. 24:5544–57
     [Google Scholar]
/content/journals/10.1146/annurev-med-080122-030714
Loading
Mpox: The Reemergence of an Old Disease and Inequities
Annual Review of Medicine 75, 159 (2024); https://doi.org/10.1146/annurev-med-080122-030714
/content/journals/10.1146/annurev-med-080122-030714
/content/journals/10.1146/annurev-med-080122-030714
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error